LOARGYS

This brand name is authorized in Austria, Estonia, France, Croatia, Lithuania, United Kingdom

Active ingredients

The drug LOARGYS contains one active pharmaceutical ingredient (API):

1 Pegzilarginase UNII 4YV4KW88GD - PEGZILARGINASE

Pegzilarginase is a cobalt substituted recombinant human arginase 1 enzyme conjugated with mPEG carriers. The mPEG carrier reduces clearance of pegzilarginase resulting in an extended half-life while maintaining the functions of the enzyme. Pegzilarginase is intended to substitute for the deficient human arginase 1 enzyme activity in patients with ARG1-D. Pegzilarginase has been shown to rapidly and sustainably reduce plasma arginine and convert it to urea and ornithine. Read about Pegzilarginase

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOARGYS Solution for injection/infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AB24		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 3058365, 3058376
Country: FR	Base de données publique des médicaments	Identifier(s): 65606323
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1098465, 1098466